Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
NUVL | Nuvalent, Inc. | Director | $222M | -$64M | -22.4% | Jun 12, 2024 |
DVAX | DYNAVAX TECHNOLOGIES CORP | Director | $13.9M | Aug 8, 2023 | ||
MRSN | Mersana Therapeutics, Inc. | Director | Jun 11, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|